vTv Therapeutics Inc. (VTVT)
Nasdaq: VTVT · Pharmaceutical Preparations · High Point, NC · filing with the SEC since 2015
Who owns vTv Therapeutics Inc.
As filed with the SECHolders of 5% or more
4
Srinivas Akkaraju holds 9.9% of Class A Common Stock, par value $0.01 per share, as its SCHEDULE 13D/A filed Dec 9, 2025 says.
Directors and officers
12
report now, of 33 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Srinivas Akkaraju
SCHEDULE 13D/A · filed Dec 9, 2025 · Class A Common Stock, par value $0.01 per share · 9.9% in Sep 25, 2025
Trails Edge Capital Partners, LP
SCHEDULE 13G · filed Sep 8, 2025 · Common Stock, par value $0.01 per share
Raymond Debbane
SCHEDULE 13G/A · filed Nov 12, 2025 · Class A Common Stock, $0.01 par value per share · 9.99% in Sep 8, 2025
Millennium Management LLC
SCHEDULE 13G/A · filed Oct 8, 2026 · Class A Common Stock, par value $0.01 per share · 6.9% in Jul 29, 2026
What VTVT reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 10, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.